Literature DB >> 19463511

Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes.

Alan J Bagnall1, Shaun G Goodman, Keith A A Fox, Raymond T Yan, Joel M Gore, Asim N Cheema, Thao Huynh, Denis Chauret, David H Fitchett, Anatoly Langer, Andrew T Yan.   

Abstract

Randomized controlled trials support the use of an early invasive strategy in high-risk patients with non-ST-segment elevation (NSTE) acute coronary syndromes (ACS). Although risk increases with age, limited data are available to support this strategy in older patients. The aims of this study were to examine temporal trends in the management and outcomes of NSTE ACS in elderly patients and to explore reasons for the lower use of early angiography in the aged population. Data from 11,732 patients with NSTE ACS were collected from 3 consecutive Canadian registries (ACS I, ACS II, and Global Registry of Acute Coronary Events [GRACE]/GRACE2) from 1999 to 2007. Rates of in-hospital cardiac catheterization, revascularization, infarction or reinfarction, and death were stratified by age (<65, 65 to 74, and > or = 75 years). Although overall, rates of in-hospital catheterization and revascularization increased over time (p <0.001), the largest increase occurred in patients aged <65 years. The strongest independent negative predictor of the use of cardiac catheterization was age > or = 75 years (adjusted odds ratio 0.45, 95% confidence interval 0.37 to 0.56, p <0.001). Use of an early invasive approach was associated with a reduction in 1-year mortality across all age groups, but the absolute difference was greatest in patients aged > or = 75 years. The underestimation of risk by physicians (ascertained in ACS II) was the most common reason for choosing a conservative strategy. In conclusion, despite an overall increased use of an early invasive strategy, elderly patients with NSTE ACS remain significantly less likely to undergo cardiac catheterization and revascularization and are often erroneously perceived to be at low risk by their physicians. Future studies should determine whether more aggressive treatment of these high-risk elderly patients improves outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19463511     DOI: 10.1016/j.amjcard.2009.01.369

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Acute coronary syndromes in octogenarians referred for invasive evaluation: treatment profile and outcomes.

Authors:  Milosz Jaguszewski; Jelena-R Ghadri; Johanna Diekmann; Roxana D Bataiosu; Jens P Hellermann; Annahita Sarcon; Asim Siddique; Lukas Baumann; Barbara E Stähli; Thomas F Lüscher; Willibald Maier; Christian Templin
Journal:  Clin Res Cardiol       Date:  2014-08-21       Impact factor: 5.460

Review 2.  Exclusion of older adults and women from recent trials of acute coronary syndromes.

Authors:  Katherine S Dodd; Jane S Saczynski; Yanfang Zhao; Robert J Goldberg; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2011-03-01       Impact factor: 5.562

3.  Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study.

Authors:  Kristin Marie Kvakkestad; Jon Michael Gran; Jan Eritsland; Charlotte Holst Hansen; Eigil Fossum; Geir Øystein Andersen; Sigrun Halvorsen
Journal:  Cardiology       Date:  2019-11-05       Impact factor: 1.869

4.  Impact of myocardial revascularization on long-term outcomes in a nationwide cohort of first acute myocardial infarction survivors.

Authors:  Leonardo De Luca; Paola D'Errigo; Stefano Rosato; Gian Francesco Mureddu; Gabriella Badoni; Fulvia Seccareccia; Giovanni Baglio
Journal:  Eur Heart J Suppl       Date:  2022-05-18       Impact factor: 1.624

5.  The Impacts of In-Hospital Invasive Strategy on Long-Term Outcome in Elderly Patients with Non-ST-Elevation Myocardial Infarction.

Authors:  Shao-Sung Huang; Hsin-Bnag Leu; Tse-Min Lu; Tao-Cheng Wu; Ying-Hwa Chen; Jaw-Wen Chen; Shing-Jong Lin; Wan-Leong Chan
Journal:  Acta Cardiol Sin       Date:  2013-03       Impact factor: 2.672

6.  The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry.

Authors:  Christopher J Malkin; Roshan Prakash; Derek P Chew
Journal:  BMJ Open       Date:  2012-02-16       Impact factor: 2.692

7.  Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy.

Authors:  Christian Roth; Clemens Gangl; Daniel Dalos; Lisa Krenn; Sabine Scherzer; Anna Gerken; Martin Reinwein; Chao Zhang; Michael Hagmann; Thomas Wrba; Georg Delle-Karth; Thomas Neunteufl; Gerald Maurer; Paul Vock; Harald Mayr; Bernhard Frey; Rudolf Berger
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

8.  Effects of geodemographic profiles on healthcare service utilization: a case study on cardiac care in Ontario, Canada.

Authors:  Li Tao; Jiming Liu; Bo Xiao
Journal:  BMC Health Serv Res       Date:  2013-07-01       Impact factor: 2.655

9.  International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries.

Authors:  R L McNamara; S C Chung; T Jernberg; D Holmes; M Roe; A Timmis; S James; J Deanfield; G C Fonarow; E D Peterson; A Jeppsson; H Hemingway
Journal:  Int J Cardiol       Date:  2014-05-09       Impact factor: 4.164

10.  Disparities in a provision of in-hospital post-arrest interventions for out-of-hospital cardiac arrest (OHCA) in the elderly population-protocol for a systematic review.

Authors:  Joanna M Bielecki; Josephine Wong; Nicholas Mitsakakis; Prakesh S Shah; Murray D Krahn; Valeria E Rac
Journal:  Syst Rev       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.